PF-Atlas › Weekly Digest
Weekly IPF Research Digest
A short, plain-language recap of IPF research, one issue a week. Tap an issue to read the full digest.
Get IPF progress updates by email
This is not a newsletter. It is the real movement in the fight against idiopathic pulmonary fibrosis. New trials opening, new treatments being tested, where the best options stand now, in plain language, once a week. If you or someone you love is living with IPF, this is the progress you want to follow. Confirm your address to start. Unsubscribe anytime.
We email a confirmation link first, so it is really you. No spam, ever.
Two New Phase II Trials Enter the IPF Pipeline as Research Activity Stays HighNew
Read the full digest →
A New Real-World Nerandomilast Study Opens, Lung Scarring Cell Biology Gets Clearer, and Our Own AI Solver Tests 20 Drug Cocktails
Read the full digest →
Nerandomilast Gets Its Close-Up, Our Solver Reaches 19 Candidates, and Twelve New Papers Land
Read the full digest →
Lung Cell Flexibility, Genetic Risk Across Populations, and Our Solver's Best Formula Yet: IPF Week of Oct 19 to 26, 2026
Read the full digest →
A New Inhaled Drug Enters Testing, a Fat-Protein Finding Surprises Researchers, and Our Own Software Explores 134 Drug Combinations
Read the full digest →
Four New Trials Open, Inhaled Treprostinil Debated in NEJM, and Our Solver Hits 133 Combinations
Read the full digest →
New Phase 2 and Phase 3 Trials Open, Stem Cell Exosome Study Earns Study of the Week
Read the full digest →
IPF Research Digest, September 27 to October 4, 2026: Twelve New Papers, No New Trials, and Four Computer-Generated Hypotheses From Our Own Software
Read the full digest →
PDE4 Inhibitors in the Spotlight, a New Breathing Trial Opens, and Our AI Flags Three Inhaled Drug Candidates
Read the full digest →Medical disclaimer. This digest summarizes public clinical-trial and research data in plain language for information only. It is not medical advice, a treatment recommendation, or a promise of any outcome. Evidence changes; treatments described as investigational are not proven cures. Always verify with ClinicalTrials.gov, PubMed and a qualified pulmonologist before any decision.